Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study to Evaluate Tobevibart+Elebsiran in Participants With Chronic HDV Infection Not Virologically Suppressed With Bulevirtide
Sponsor: Vir Biotechnology, Inc.
Summary
This is a multicenter, open label, randomized Phase 3 clinical study to evaluate tobevibart + elebsiran in participants with Chronic HDV Infection not virologically suppressed with bulevirtide
Official title: A Phase 3 Randomized, Open-Label Study to Evaluate the Efficacy and Safety of Tobevibart+Elebsiran Combination Therapy in Participants With Chronic HDV Infection Not Virologically Suppressed With Bulevirtide (ECLIPSE 2)
Key Details
Gender
All
Age Range
18 Years - 70 Years
Study Type
INTERVENTIONAL
Enrollment
150
Start Date
2025-07-30
Completion Date
2031-07
Last Updated
2026-03-31
Healthy Volunteers
No
Conditions
Interventions
Tobevibart
Tobevibart administered by subcutaneous injection
Elebsiran
Elebsiran administered by subcutaneous injection
Bulevirtide
Bulevirtide administered by subcutaneous injection
Locations (36)
Investigative Site
Innsbruck, Austria
Investigative Site
Vienna, Austria
Investigative Site
Bobigny, France
Investigative Site
Clichy, France
Investigative Site
Créteil, France
Investigative Site
Le Chesnay, France
Investigative Site
Limoges, France
Investigative Site
Lyon, France
Investigative Site
Montpellier, France
Investigative Site
Pessac, France
Investigative Site
Rennes, France
Investigative Site
Toulouse, France
Investigative Site
Villejuif, France
Investigative Site
Berlin, Germany
Investigative Site
Essen, Germany
Investigative Site
Frankfurt am Main, Germany
Investigative Site
Hanover, Germany
Investigative Site
Bergamo, Italy
Investigative Site
Milan, Italy
Investigative Site
Milan, Italy
Investigative Site
Pisa, Italy
Investigative Site
Torino, Italy
Investigative Site
Bucharest, Romania
Investigative Site
Bucharest, Romania
Investigative Site
Bucharest, Romania
Investigative Site
Craiova, Romania
Investigative Site
Barcelona, Spain
Investigative Site
Barcelona, Spain
Investigative Site
Madrid, Spain
Investigative Site
Madrid, Spain
Investigative Site
Santander, Spain
Investigative Site
London, United Kingdom
Investigative Site
London, United Kingdom
Investigative Site
London, United Kingdom
Investigative Site
Manchester, United Kingdom
Investigative Site
Nottingham, United Kingdom